vimarsana.com

Page 124 - ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tia and CommonSpirit Health Team Up to Deliver Integrated, Person-Based Care for Women

Tia, the modern medical home for women, and CommonSpirit Health, the nation s largest nonprofit health system, today announced an innovative, first-of-its-kind partnership to create a new front door to healthcare for women. The deal enables the two healthcare leaders to launch Tia-branded women s health clinics together that will provide comprehensive, blended virtual and in-person care – with plans for the first clinic in Phoenix where CommonSpirit operates multiple Dignity Health medical centers. The CommonSpirit relationship is Tia s first major partnership with a national health system. The joint venture clinics will combine a multitude of services and practitioners into a one-stop shop for women that fuses gynecological care and primary care. Tia will provide its distinctive care model, staffing and technology infrastructure, while CommonSpirit will connect Tia to patients, health plan partners, and hospital and specialty care access.

United Therapeutics Announces FDA Approval and Launch of Tyvaso® for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

United Therapeutics Announces FDA Approval and Launch of Tyvaso® for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease First and only approved therapy in the United States for patients with PH-ILD, a serious, life-threatening disease with potentially more than 30,000 patients in need FDA approval based on data from the INCREASE clinical trial PH-ILD is the second FDA-approved indication for Tyvaso, which was initially approved for the treatment of pulmonary arterial hypertension News provided by Share this article Share this article SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 1, 2021 /PRNewswire/  United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food and Drug Administration (FDA) has approved Tyvaso

International March of the Living pays tribute to medical resistance and heroes of the Holocaust in symposium dedicated to Medicine and Morality

International March of the Living pays tribute to medical resistance and heroes of the Holocaust in symposium dedicated to Medicine and Morality USA - English News provided by Share this article TEL AVIV, Israel, April 1, 2021 /PRNewswire/  On April 7 th, the eve of Holocaust Remembrance Day in the Jewish calendar, International March of the Living, together with the Maimonides Institute for Ethics and the Holocaust, the Miller Center at Rutgers University, the USC Shoah Foundation and Teva Pharmaceuticals, will hold a special symposium on Medicine and Morality: Lessons from the Holocaust and COVID-19 [PROMO] Invitation for medical symposium on Medicine and Morality on April 7th, 2021 (PRNewsfoto/International March of the Living)

Ximedica announces partnership with Moderna, Inc (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines

Share this article Share this article PROVIDENCE, R.I., March 31, 2021 /PRNewswire/  Ximedica today announced a partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccines and therapeutics as part of the Defense Advanced Research Projects Agency s (DARPA) Nucleic Acids On-Demand World-Wide (NOW) Program. Integrating Moderna s proprietary mRNA technology with Ximedica s instrument design and engineering expertise, both teams will work closely together in an effort to meet capability expectations set out by the DARPA program over the 4-year partnership. As part of the agreement, Ximedica will receive up to $11 million in funding. DARPA s Nucleic Acids On-Demand World-Wide initiative aims to develop a mobile, just-in-time manufacturing platform that quickly diagnoses pathogen threats and provides medical countermeasures to deliver pandemic prevention treatments in-field. The resulting Good Manufacturing Practice (GMP) quality mRN

Carrus Acquires Archetype Innovations to Advance Next-Gen Healthcare Training

Share this article LEHI, Utah, April 1, 2021 /PRNewswire/   Carrus, one of the nation s most trusted online healthcare training and professional development providers, announced today it has completed the acquisition of Archetype Innovations (Archetype), adding the company s innovative EHR Go platform to its offerings. The addition complements Carrus existing offerings with a web-based, comprehensive electronic health record training software and opens new channels to provide education across nursing, pharmacy, therapy, informatics, and other critical allied health professions. Today s healthcare learners need meaningful experiences that help them focus on patient needs and outcomes, and including Go s educational EHR with our training will help learners prepare through diverse, customizable, real-world scenarios, said Misty Frost, CEO of Carrus. People come to us to help them improve their lives and advance their careers through exceptional healthcare learning, and incorp

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.